Originally "ROYAL CONCENTRATES" VITALIS REMEDIUM is a multi-national biopharmaceutical company that develops and manufactures regulated and approved novel advanced therapeutic drugs derived from cannabis indica. MISSION: The prove with research why cannabis is a panacea and elicit biological effects of cannabis. Offer physicians a way to prescribe cannabis efficiently. To develop medicine for the common diseases that plague mankind and make it accessible. GOALS: introduce cannabis-derived extractions into the regulated drug market become the global leader for developing and manufacturing health agency approved drugs create a universal Center for research on the endocannabinoid system. Educate physicians on the vital role of the endocannabinoid system in health, disease and why cannabis is a viable medicine
There is no investment information
No recent news or press coverage available for VITALIS REMEDIUM .